Aktiia

company

About

24/7 Blood Pressure Monitoring Made Easy

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
$17.50M
Industries
Health Care,Health Diagnostics,Medical Device,Personal Health,Wearables
Founded date
May 7, 2018
Number Of Employee
51 - 100
Operating Status
Active

Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against hypertension, Aktiia’s groundbreaking medical technology provides people and their physicians comprehensive insights into blood pressure patterns that will inform the diagnosis and management of hypertension. Now available in the United Kingdom, Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environmental protection requirements in Europe. To learn more, visit Aktiia.com.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$17.50M Fr10M
Aktiia has raised a total of $17.50M Fr10M in funding over 2 rounds. Their latest funding was raised on Nov 2, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 2, 2021 Series A $17.50M 2 Molten Ventures Detail
Mar 24, 2020 Seed Fr6M 2 Detail
Sep 25, 2018 Seed Fr4M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Aktiia is funded by 3 investors. Molten Ventures and Verve Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Molten Ventures Yes Series A
Verve Ventures Series A
Sparks Street Capital Seed